This paper is in the following e-collection/theme issue:

Randomized trials (Editor: G. Eysenbach)* (34) Virtual Reality Interventions in Mental Health (122) Extended Reality, Virtual Reality and Virtual Worlds (560) Nails and Musculoskeletal (24)

Published on in Vol 25 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/38619, first published .
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study

A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study

A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study

Authors of this article:

Katell Le Du1 Author Orcid Image ;   Anne-Lise Septans2 Author Orcid Image ;   Frédéric Maloisel3 Author Orcid Image ;   Hélène Vanquaethem4 Author Orcid Image ;   Anna Schmitt5 Author Orcid Image ;   Marielle Le Goff2 Author Orcid Image ;   Aline Clavert6 Author Orcid Image ;   Marie Zinger7 Author Orcid Image ;   Hugues Bourgeois2 Author Orcid Image ;   Olivier Dupuis2 Author Orcid Image ;   Fabrice Denis2 Author Orcid Image ;   Stéphane Bouchard8 Author Orcid Image
Article Authors Cited by (7) Tweetations (12) Metrics

Katell Le Du   1 * , MD ;   Anne-Lise Septans   2 * , PhD ;   Frédéric Maloisel   3 * , MD, PhD ;   Hélène Vanquaethem   4 * , MD ;   Anna Schmitt   5 * , MD ;   Marielle Le Goff   2 , MD ;   Aline Clavert   6 , MD ;   Marie Zinger   7 * , MD ;   Hugues Bourgeois   2 , MD ;   Olivier Dupuis   2 , MD ;   Fabrice Denis   2 * , MD, PhD ;   Stéphane Bouchard   8 * , PhD

1 Department of Hematology, Confluent Private Hospital, Nantes, France

2 Department of Onco-Hematology, Institut inter-régionaL de Cancérologie, Centre Jean Bernard, Le Mans, France

3 Department of Onco-Hematology, Clinique Saint-Anne, Strasbourg, France

4 Department of Internal Medicine, Hôpital d’Instruction des Armées de Bégin, Saint-Mandé, France

5 Department of Hematology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France

6 Department of Hematology, Centre Hospitalo-Universitaire, Angers, France

7 Department of Onco-Hematology, Clinique Victor Hugo, Le Mans, France

8 Department of Psychoeducation and Psychology, Université du Québec en Outaouais, Gatineau, QC, Canada

*these authors contributed equally

Corresponding Author: